Former Boston unit renamed Navilyst
This article was originally published in Clinica
Executive Summary
Boston Scientific's former fluid management and vascular access businesses, which it sold to private equity firm Avista Capital Partners in February, has taken on the new name Navilyst Medical. The 800-strong, Marlborough, Massachusetts-based company manufactures implantable vascular access devices and products that control fluid levels and monitor pressure during angiography and angioplasty procedures. The firm will be headed by the former president of Boston's oncology business, Dave McClellan, who will take up the role as Navilyst's president. The chairman and CEO will be Avista's healthcare industry advisor, Ron Sparks.